tiprankstipranks
Trending News
More News >

Fosun Pharma Announces 2025 Shareholders Meeting to Discuss Share Repurchase Mandates

Story Highlights
Fosun Pharma Announces 2025 Shareholders Meeting to Discuss Share Repurchase Mandates

Don’t Miss TipRanks’ Half-Year Sale

An announcement from Shanghai Fosun Pharmaceutical (Group) Co ( (HK:2196) ) is now available.

Shanghai Fosun Pharmaceutical has announced a 2025 H Shareholders class meeting to discuss and potentially approve resolutions for granting the board a general mandate to repurchase H Shares and A Shares. This move aims to preserve company value and protect shareholder interests, reflecting a strategic effort to strengthen its market position and enhance shareholder value.

More about Shanghai Fosun Pharmaceutical (Group) Co

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a joint stock limited company incorporated in the People’s Republic of China, operating in the pharmaceutical industry. The company focuses on the development, manufacture, and sale of pharmaceutical products, medical devices, and healthcare services, with a market presence in China and internationally.

Average Trading Volume: 5,143,571

Technical Sentiment Signal: Sell

Current Market Cap: HK$62.5B

Find detailed analytics on 2196 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1